New hope for rare muscle diseases: experimental drug shows promise in long-term trial
NCT ID NCT04628936
First seen Nov 19, 2025 · Last updated May 23, 2026 · Updated 22 times
Summary
This study looked at the long-term safety and effectiveness of an experimental drug called KZR-616 in people with active polymyositis or dermatomyositis, two rare diseases that cause muscle inflammation and weakness. The 18 participants had already completed a previous study and continued taking KZR-616 for up to 48 weeks. Researchers measured improvement using a total improvement score, with higher scores meaning better results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATOMYOSITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
KZR Research Site
Beverly Hills, California, 90211, United States
-
KZR Research Site
Orange, California, 92868, United States
-
KZR Research Site
Miami, Florida, 33136, United States
-
KZR Research Site
Kansas City, Kansas, 66160, United States
-
KZR Research Site
Baltimore, Maryland, 21224, United States
-
KZR Research Site
Ann Arbor, Michigan, 48109, United States
-
KZR Research Site
Duncansville, Pennsylvania, 16635, United States
-
KZR Research Site
Pittsburgh, Pennsylvania, 15213, United States
-
KZR Research Site
Austin, Texas, 78756, United States
-
KZR Research Site
Prague, Czechia
Conditions
Explore the condition pages connected to this study.